NEW YORK and BERLIN, May 02, 2023 (GLOBE NEWSWIRE) — atai Life Sciences (NASDAQ: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, will participate in the 2023 Aegis Virtual Conference. Details of the company’s presentation is as follows: Aegis Virtual Conference Format: Corporate Presentation Date and Time: Wednesday, May 3rd…


Previous articlePT408 – Fireside Project: Harm Reduction Through Free Peer Support
Next articlePsychedelics, The Brain, and the Future of Mental Health